DFDA

Endovascular Revascularization (Angioplasty & Stenting)

Treatment for Vascular Intestinal Disorders

Effectiveness
85%
Safety Score
50%
Clinical Trials
80
Participants
6K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate
Treatment Duration
Single procedure, long-term monitoring
Evidence Quality
MODERATE
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$700
Side Effect Mgmt:$500
Total Annual:$1,300
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$75,000/QALY
QALYs Gained
2
Outcome-Based Costs
Cost per Responder
$1,529
Cost per Remission
$1,733
Comparison vs Open Surgical Revascularization
Cost Difference
$-15,000/year
Less expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Endovascular Revascularization (Angioplasty & Stenting) Outcomes

for Vascular Intestinal Disorders

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+75%
Common Side Effects
Access site hematoma/bleeding
+7%
Stent restenosis
+15%
Contrast nephropathy
+7%

Sources:

nih.gov
nih.gov
elsevierpure.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov